CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (174,668)	$ (128,310)
Adjustments to net income (loss):
Depreciation and amortization	164,360	177,277
Deferred income tax expense (benefit)	3,721	(1,178)
Impairments and other charges		355
Amortization of debt discount and deferred financing costs	4,984	5,400
Losses (gains) on debt buyback	36	(8,062)
Losses (gains) on long-lived assets, net	77	8,524
Losses (gains) on investments, net	1	(315)
Provision (recovery) of bad debt		(2,339)
Share-based compensation	3,879	6,775
Foreign currency transaction losses (gains), net	4,214	2,365
Mark-to-market loss on warrants	71,752
Noncontrolling interest	(9,828)	(8,777)
Other	110	398
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(22,775)	32,017
Inventory	(5,621)	6,039
Other current assets	(8,039)	(6,476)
Other long-term assets	2,136	(4,949)
Trade accounts payable and accrued liabilities	2,024	(17,697)
Income taxes payable	682	15,766
Other long-term liabilities	4,309	2,677
Net cash provided by (used for) operating activities	41,354	79,490
Cash flows from investing activities:
Purchases of investments	(1,534)	(14)
Sales and maturities of investments	5	10,908
Capital expenditures	(84,258)	(40,852)
Proceeds from sales of assets and insurance claims	3,671	10,839
Other	9
Net cash (used for) provided by investing activities	(82,107)	(19,119)
Cash flows from financing activities:
Reduction in long-term debt	(86,127)	(16,838)
Debt issuance costs	(3,858)	(2,421)
Proceeds from revolving credit facilities	40,000	95,000
Reduction in revolving credit facilities	(500,000)	(135,000)
Proceeds from issuance of common shares, net of issuance costs	257
Repurchase of common and preferred shares	(4,523)
Dividends to common and preferred shareholders	(10)	(3,662)
Distributions to noncontrolling interest	(995)	(49,077)
Other		(1,923)
Net cash (used for) provided by financing activities	(555,256)	(113,921)
Effect of exchange rate changes on cash and cash equivalents	(1,289)	(1,111)
Net increase (decrease) in cash and cash equivalents and restricted cash	(597,298)	(54,661)
Cash and cash equivalents and restricted cash, beginning of period	1,273,510	475,280
Cash and cash equivalents and restricted cash, end of period	676,212	420,619
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	991,471	472,246
Restricted cash, beginning of period	282,039	3,034
Cash and cash equivalents and restricted cash, beginning of period	1,273,510	475,280
Cash and cash equivalents, end of period	394,028	417,544
Restricted cash, end of period	282,184	3,075
Cash and cash equivalents and restricted cash, end of period	$ 676,212	$ 420,619